Cardiovascular Diabetology

JANUARY 23, 2025

Diabetes mellitus (DM) and proteinuria each independently raise the risk of atrial fibrillation (AF). We aimed to investigate the relationship between proteinuria and the risk of incident AF across glycemic st.

Atrial Fibrillation 52

Atrial Fibrillation Diabetes Research 52

Frontiers in Cardiovascular Medicine

DECEMBER 13, 2023

Cancer, atrial fibrillation (AF) and coronary artery disease share some common factors and interact with each other, such as obesity, aging, diabetes, and inflammation, but the potential specific mechanism is still unclear. Meanwhile, the risk of suffering from cardiovascular disease (CVD) has been increasing with ageing.

Cancer 64

Cancer Atrial Fibrillation Embolism Coronary Artery Disease 64

HeartRhythm

MARCH 31, 2025

Atrial fibrillation (AF) affects over 60 million individuals worldwide. Diabetes mellitus (DM) is recognized as an independent risk factor for AF development. Hypomagnesemia (HypoMg) is frequently comorbid with DM and AF. Mg2+ has been used to treat AF patients and also improves DM-associated cardiac diastolic dysfunction.

Atrial Fibrillation 40

Atrial Fibrillation Diabetes Risk Factors 40

HeartRhythm

APRIL 30, 2024

Diabetes mellitus (DM) is a major risk factor for the development of atrial fibrillation). The mechanism for the development of AF in DM is poorly understood.

Atrial Fibrillation 40

Atrial Fibrillation Diabetes Risk Factors 40

HeartRhythm

FEBRUARY 20, 2024

Diabetes mellitus (DM) is a major risk factor for atrial structural remodeling and atrial fibrillation (AF). Calpain activity is hypothesized to promote atrial remodeling and AF.

Atrial Fibrillation 40

Atrial Fibrillation Diabetes Risk Factors 40

Heart BMJ

MARCH 26, 2025

Patients with myocardial infarction with two or more risk factors among elevated pulse pressure, aortic valve peak velocity, diabetes and atrial fibrillation had over 16 times the risk of developing heart failure with preserved ejection fraction compared with those without these risk factors (p<0.001). m/s had a 2.10-fold

Myocardial Infarction 52

Myocardial Infarction Aortic valve Preserved Ejection Fraction Heart Failure 52

CardiacWire

SEPTEMBER 11, 2024

A JACC study suggests that atrial fibrillation is far more prevalent than many previously thought, estimating that nearly one in 20 American adults have been diagnosed with the disease. That increase was greatest among younger patients, males, minorities, and patients with hypertension and diabetes. adult population.

AFIB 105

AFIB Atrial Fibrillation Research Arrhythmia 105

HeartRhythm

JANUARY 23, 2025

The prevalence of atrial fibrillation (AF) in patients with type 2 diabetes mellitus (T2DM) is reported to be higher than in the general population, ranging from 3.6% to 8.9 % [1].

Atrial Fibrillation 40

Atrial Fibrillation Diabetes Outcomes Cardiovascular Disease 40

HeartRhythm

MARCH 12, 2024

Diabetes mellitus (DM) is a public health problem that continues to grow worldwide. 1 Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting more than 6 million individuals in the United States.2 In the United States the Center for Disease Control and Prevention estimates that it affects 11.6%

Atrial Fibrillation 40

Atrial Fibrillation Diabetes Public Health Obesity 40

Circulation

NOVEMBER 11, 2024

Introduction:Stroke prevention with anticoagulation is an important aspect of atrial fibrillation (AF) management. Diabetes is accepted as a risk factor for stroke in AF, but the threshold at which stroke risk increases is uncertain. male), of whom 64,972 (27.8%) had diabetes. male), of whom 64,972 (27.8%) had diabetes.

Atrial Fibrillation 40

Atrial Fibrillation Diabetes Stroke Strokes 40

AMS Cardiology

DECEMBER 14, 2023

Atrial fibrillation often shortened to AFib is an irregular and often rapid heart rhythm that can lead to serious health complications. Control Underlying Medical Conditions – If you have diabetes, high blood pressure or other medical conditions that increase your risk of AFib, it’s crucial to manage them properly.

Atrial Fibrillation 52

Atrial Fibrillation AFIB Blood Clot Heart Rhythm 52

HeartRhythm

APRIL 30, 2024

While no dedicated trials of GLP-1 agonists in the atrial fibrillation (AF) population have been reported, diabetes trials demonstrated lower risk of AF occurrence. Semaglutide is a GLP-1 agonist that modulates metabolism and is shown to have significant cardiovascular outcome benefits.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Diabetes Outcomes 40

HeartRhythm

MARCH 31, 2025

Obese patients with atrial fibrillation (AF) are at an increased risk of thromboembolic and bleeding events due to a prothrombotic state and comorbidities such as hypertension and diabetes.

Atrial Fibrillation 40

Atrial Fibrillation Obesity Outcomes Diabetes 40

HeartRhythm

MARCH 31, 2025

Obese patients with atrial fibrillation (AF) are at an increased risk of thromboembolic and bleeding events due to a prothrombotic state and comorbidities such as hypertension and diabetes.

Atrial Fibrillation 40

Atrial Fibrillation Obesity Outcomes Diabetes 40

HeartRhythm

APRIL 30, 2024

Diabetes Mellitus (DM) significantly elevates the risk of Atrial Fibrillation (AF) and stroke. While Sodium-Glucose Cotransporter 2 (SGLT2) inhibitors have shown cardiovascular benefits in DM patients, their causal effect on AF risk and ischemic stroke remains largely unexplored.

Atrial Fibrillation 40

Atrial Fibrillation Stroke Strokes Diabetes 40

American College of Cardiology

JANUARY 8, 2024

Obesity is a multifaceted disease that is directly and indirectly implicated in atherosclerotic cardiovascular disease (CVD), heart failure (HF), atrial fibrillation (AF), and multiple CVD risk factors, including dyslipidemia, hypertension, type 2 diabetes mellitus (DM), and sleep disorders.

Obesity 70

Obesity Atrial Fibrillation Heart Failure Risk Factors 70

Journal of the American Heart Association

FEBRUARY 26, 2025

BackgroundMultimorbidity is common among patients with atrial fibrillation (AF) and is associated with worse outcomes. Multimorbidity was defined as 2 comorbidities (heart failure, hypertension, diabetes, coronary heart disease, kidney dysfunction, moderate or severe mitral valve regurgitation, or obesity).

Atrial Fibrillation 53

Atrial Fibrillation Bicuspid/Mitral Obesity Heart Failure 53

Journal of Cardiovascular Electrophysiology

JANUARY 9, 2025

ABSTRACT Atrial fibrillation (AF) is the most common cause of arrhythmia-induced cardiomyopathy. Sodium-glucose co-transporter 2 inhibitors (SGLT2i), a novel class of antidiabetic drugs, have shown a promising impact in reducing cardiovascular events in diabetic and nondiabetic heart failure (HF) patients.

Atrial Fibrillation 40

Atrial Fibrillation Diabetes Ablation Hospital 40

Journal of Cardiovascular Electrophysiology

FEBRUARY 20, 2024

In patients with atrial fibrillation (AF) ablation and diabetes mellitus (DM), the prevalence of left atrial low-voltage areas (LVAs) increased with increasing glycated hemoglobin A1c (HbA1c) level. In patients with LVAs, freedom from AF recurrence was lower in patients who had DM with HbA1c ≥7% than in those without DM.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Diabetes Outcomes 40

Journal of the American Heart Association

DECEMBER 12, 2023

BackgroundThe association between sodium‐glucose cotransporter 2 inhibitors (SGLT2i) and atrial fibrillation (AF) recurrence after catheter ablation among patients with diabetes and AF remains unclear.Methods and ResultsPatients with AF undergoing initial catheter ablation with a history of diabetes from the China AF registry were included.

Atrial Fibrillation 40

Atrial Fibrillation Diabetes Ablation Outcomes 40

Frontiers in Cardiovascular Medicine

DECEMBER 18, 2024

Atrial fibrillation (AF), the most prevalent cardiac arrhythmia, is closely linked to metabolic dysfunctions, including obesity, diabetes, and dyslipidemia. These lead to pathological changes in myocardial metabolism and mitochondrial energy metabolism, thereby aggravating AF's incidence and severity.

Atrial Fibrillation 40

Atrial Fibrillation Exercise Pharmacology Obesity 40

European Journal of Heart Failure

DECEMBER 18, 2024

Development of a machine learning model to predict new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy. Aims Atrial fibrillation (AF) is the most common sustained arrhythmia among patients with hypertrophic cardiomyopathy (HCM), leading to increased symptom burden and risk of thromboembolism.

Atrial Fibrillation 40

Atrial Fibrillation Cardiomyopathy Exercise Arrhythmia 40

HeartRhythm

APRIL 30, 2024

Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are anti-diabetic medications that effectively enhance cardiovascular outcomes in individuals with type 2 diabetes mellitus (T2DM).

Diabetes 40

Diabetes Atrial Fibrillation Outcomes 40

Circulation

NOVEMBER 11, 2024

Background:Clinical studies on atrial fibrillation (AF) recurrence after catheter ablation in patients diagnosed with patent foramen ovale (PFO) and paroxysmal AF (PAF) are scarce. The constructed nomogram included four clinical variables: age, diabetes mellitus, lipoprotein (a), and right ventricular diameter.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Risk Factors Diabetes 40

All About Cardiovascular System and Disorders

FEBRUARY 27, 2024

They have a greater prevalence of obesity, dyslipidemia, metabolic syndrome and diabetes mellitus. Higher risk of myocardial infarction, heart failure and atrial fibrillation was noted in spinal cord injury survivors compared to controls. Survivors with severe disability had the highest risk. Am J Phys Med Rehabil. 2023.12.010.

Myocardial Infarction 40

Myocardial Infarction Atrial Fibrillation Heart Failure Blood Pressure 40

DAIC

DECEMBER 8, 2023

Getty Images milla1cf Fri, 12/08/2023 - 08:17 December 8, 2023 — The American College of Cardiology (ACC) and the American Heart Association (AHA), along with several other leading medical associations, have issued a new guideline for preventing and optimally managing atrial fibrillation (AFib).

Atrial Fibrillation 52

Atrial Fibrillation AFIB Stroke Strokes 52

Journal of Cardiovascular Electrophysiology

MARCH 3, 2025

ABSTRACT Background Atrial fibrillation (AF) recurrence remains a significant challenge in heart failure with reduced ejection fraction (HFrEF) patients undergoing cryoballoon ablation (CBA). Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have demonstrated cardiovascular benefits, including antiarrhythmic effects.

Heart Failure 40

Heart Failure Atrial Fibrillation Ablation Outcomes 40

Journal of the American Heart Association

MARCH 21, 2025

BackgroundThe clinical utility of the polygenic risk score in predicting cardiovascular events in patients with atrial fibrillation (AF) has not yet been established. Journal of the American Heart Association, Ahead of Print.

Atrial Fibrillation 40

Atrial Fibrillation Myocardial Infarction Stroke Strokes 40

Stroke Journal

JANUARY 30, 2025

Introduction:Intracranial hemorrhage (ICH) is the most severe adverse effect of anticoagulation in atrial fibrillation (AF) patients. Hypertension, diabetes, hyperlipidemia, and chronic kidney disease are well-known cardiovascular risk factors for ICH. Stroke, Volume 56, Issue Suppl_1 , Page A49-A49, February 1, 2025.

Atrial Fibrillation 40

Atrial Fibrillation Hemorrhage Risk Factors Kidney Disease 40

Journal of Cardiovascular Electrophysiology

NOVEMBER 5, 2023

Abstract Introduction Influence of early atrial fibrillation (AF) ablation, particularly cryoballoon ablation (CBA), on clinical outcome during long-term follow-up has not been clarified. The primary outcome was recurrence of atrial tachyarrhythmias (ATs) of ≥30-s after a 3-month blanking period. vs. 31.7%, p  = 0.043).

Atrial Fibrillation 40

Atrial Fibrillation Ablation Outcomes Kidney Disease 40

Circulation

JUNE 4, 2024

Diabetes (16.3% to 6.4%), atrial fibrillation (1.7% We projected through 2050, overall and by age and race and ethnicity, accounting for changes in disease prevalence and demographics.RESULTS:We estimate that among adults, prevalence of hypertension will increase from 51.2% in 2020 to 61.0% to 26.8%) and obesity (43.1%

Risk Factors 81

Risk Factors Cardiovascular Disease Stroke Strokes 81

The American Journal of Cardiology

MARCH 8, 2025

Publication date: Available online 7 March 2025 Source: The American Journal of Cardiology Author(s): George G. Kidess, Mohammad Hamza, Rohit Goru, Jawad Basit, Mowaffak Alraiyes, M Chadi Alraies

Atrial Fibrillation 40

Atrial Fibrillation Diabetes 40

Circulation

NOVEMBER 11, 2024

of senior patients with age-related diseases such as hypertension, dyslipidemia and atrial fibrillation had PVTs, as estimated by cardiac computed tomography (CT) and transesophageal echocardiography (TEE). Patients with type 2 diabetes mellitus (T2DM) must have PVTs. In 2022, we reported that 98.6% from 50 y.o.

Pulmonary 45

Pulmonary Diabetes Atrial Fibrillation Hypertension 45

Circulation

JUNE 4, 2024

The human capital approach was used to estimate productivity losses from morbidity and premature mortality due to cardiovascular conditions.RESULTS:One in 3 US adults received care for a cardiovascular risk factor or condition in 2020.

Cardiovascular Disease 75

Cardiovascular Disease Stroke Strokes Risk Factors 75

DAIC

JUNE 18, 2024

The last decade has seen a surge of cardiovascular risk factors such as uncontrolled high blood pressure, diabetes and obesity, each of which raises the risks of developing heart disease and stroke," he said. "It The diabetes rate is expected to rise from 16.3% This includes a doubling of stroke rates. of the population.

Heart Disease 105

Heart Disease Blood Pressure Stroke Strokes 105

Journal of the American Heart Association

DECEMBER 29, 2023

Obesity significantly increases AF risk, both directly and indirectly, through related conditions, like hypertension, diabetes, and heart failure. AF increases the risk of stroke, heart failure, dementia, and hospitalization.

Obesity 45

Obesity Atrial Fibrillation Heart Failure Pharmacology 45

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Type 2 Diabetes Mellitus (T2DM) is a rapidly growing global health problem with increasing prevalence. Of those patients, 35.43% (n=273,993) were diabetic and 64.57% (n=151,112) were non‐diabetic. Diabetics were more likely to be younger (70.43 Among diabetics, readmitted patients were more likely to be older (71.87

Diabetes 40

Diabetes Coronary Artery Disease Atrial Fibrillation Dementia 40